focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.30
Bid: 7.25
Ask: 7.35
Change: 0.00 (0.00%)
Spread: 0.10 (1.379%)
Open: 7.30
High: 7.30
Low: 7.30
Prev. Close: 7.30
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

9 Apr 2008 10:18

Phytopharm PLC09 April 2008 TR-1: notification of major interests in shares 1. Identity of the issuer or Phytopharm plcthe underlying issuer of existing shares to which votingrights are attached: 2. Reason for the notification (please tick the appropriate box or boxes) An acquisition or disposal of voting rights YESAn acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify): Placing 3. Full name of person(s) AXA S.A, 25 Avenue Matignon, subject to the notification 75008 Paris and its group of companiessubject to the notification obligation: 4. Full name of shareholder(s)(if different from 3.) 5. Date of the transaction (and 02/04/08date on which the threshold is crossed or reached ifdifferent) 6. Date on which issuer 03/04/08notified: 7. Threshold(s)that is/arecrossed orreached: 6% 8. Notified details: A: Voting rights attached to sharesClass/type Situation previous to the Resulting situation after the triggeringof shares Triggering transaction transactionif possibleusing the Number of Number of Number of Number of voting % of votingISIN CODE Shares Voting shares rights rights Rights Direct Direct x Indirect xi Direct IndirectOrdinary 1Pence 4,095,079 4,095,079 11,000 11,000 5,737,517 0.01% 6.07%GB000686972 B: Financial InstrumentsResulting situation after the triggering transactionType of Expiration Exercise/ Number of voting rights that may % offinancial date Conversion be acquired if the instrument is votinginstrument Period/ Date exercised/ converted. rights Total (A+B)Number of voting rights % of voting rights5,748,517 6.08%9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: Name of the Company/Fund Number of Shares % of issued share capitalAXA UK Investment Co ICVC UKSmaller Companies Fund 325 0.00034IndirectFramlington Goldmans 337,984 0.35749IndirectSun Life Pensions ManagementLtd 11,000 0.01163DirectAXA Framlington Equity Income 3,340,768 3.53356IndirectAXA Framlington Biotech 1,052,631 1.11338IndirectFramlington onshore privateclients 477,181 0.50472IndirectFramlington onshore privateclients 43,863 0.04639IndirectAXA Framlington St James PlaceInternal Equity & Income UT 484,765 0.51274Indirect Total direct 11,000 0.01163 Total Indirect 5,737,517 6.06862 Total 5,748,517 6.08025 Proxy Voting:10. Name of the proxy holder:11. Number of voting rights proxy holder will cease to hold:12. Date on which proxy holder will cease to hold voting rights:13. Additional Notification using the total voting rights figure ofinformation: 94,544,03814. Contact name: Zoe McGowan, Company Secretary15. Contacttelephone number: 01480 437697 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th May 20247:00 amRNSNotice of half year results
15th Apr 20247:00 amRNSLife Molecular Imaging – Neuraceq Supply Agreement
3rd Apr 20247:00 amRNSImeka Collaboration Agreement
13th Mar 20247:00 amRNSTrading Update
29th Jan 202412:00 pmRNSHolding(s) in Company
25th Jan 20244:00 pmRNSResult of AGM
12th Jan 20249:35 amRNSDirectorate Change
27th Dec 20237:00 amRNSUpdate regarding Nominated Adviser and Broker
15th Dec 20237:00 amRNSChange of Auditor
5th Dec 20237:00 amRNSFinancial Results for year ended 30 September 2023
27th Nov 20237:00 amRNSNotice of Results and Investor Presentation
5th Oct 20237:00 amRNSAppointment of Independent Non-Executive Director
29th Sep 20237:00 amRNSTrading Update
18th Jul 20237:00 amRNSContract Win
14th Jun 20237:00 amRNSContract Win
23rd May 20237:00 amRNSHalf year report
16th May 20237:00 amRNSInvestor Meet Company presentation
10th May 20237:00 amRNSTrading Update
3rd Apr 20238:35 amRNSExtension of Huntington's disease consortium
21st Mar 202312:11 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSContract Win
7th Feb 20237:00 amRNSTrading Update
31st Jan 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20232:05 pmRNSSecond Price Monitoring Extn
31st Jan 20232:00 pmRNSPrice Monitoring Extension
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
27th Jan 20231:00 pmRNSResult of AGM
3rd Jan 20237:00 amRNSTotal Voting Rights
22nd Dec 202212:18 pmRNSDirector Bed & ISA Dealing
13th Dec 20227:00 amRNSPDMR Exercise of Options
9th Dec 20229:05 amRNSContract Win
8th Dec 20223:34 pmRNSContract Update
7th Dec 20227:00 amRNSFinancial Results for the year ended 30 Sept 2022
21st Nov 20227:00 amRNSNotice of Results and Investor Presentation
25th Oct 20227:00 amRNSTrading Update
21st Sep 202210:35 amRNSHD-IH Consortium
14th Sep 20227:00 amRNSGrant of Share Options
1st Sep 20227:00 amRNSTrading Update and FY2023 Guidance
4th Aug 20227:00 amRNSContract Win
26th Jul 202211:22 amRNSContract Win - Replacement
21st Jul 20227:00 amRNSContract Win
14th Jun 20227:00 amRNSContract Extension
24th May 20227:00 amRNSHalf-year Report and Trading Update
16th May 20227:00 amRNSInvestor Presentation
10th May 20227:00 amRNSConsortium Agreement in Huntington's Disease
25th Apr 20227:00 amRNSTrading Update
21st Apr 20227:00 amRNSNew Contract Win
8th Mar 20227:00 amRNSContract worth circa £800k
14th Feb 20227:00 amRNSLaunch of IXIQ.Ai Deep learning AI-based platform

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.